AI MARKET SCANNING

Harrow Inc

📅 Next Catalyst: Nov 09, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP -1.34%
MAX GAP RECORD +43.22%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $HROW
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 09, 2026 Earnings Release 2026-11-09 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE)
-4.18%
May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE)
-10.96%
Mar 02, 2026 Earnings Release 2026-03-02 (AFTER CLOSE)
-16.68%
Nov 10, 2025 Earnings Release 2025-11-10 (AFTER CLOSE)
-0.41%
Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE)
+6.70%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
+0.73%
Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE)
-19.40%

VOLATILITY & GAP BIAS

AVG GAP MOVE 12.4%
Bullish Gaps (5)
Bearish Gaps (7)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $HROW

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗